INTEGRATED FILING — Other than Banks



General information about company

Scrip code 000000
NSE Symbol VISAMAN
MSEI Symbol NOTLISTED
ISIN INE0BHK01012
Name of Company VISAMAN GLOBAL SALES LIMITED
Type of company SME
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 29-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 22-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Half Yearly
Reporting Quarter Yearly
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Trading Business
Start date and time of board meeting 29-May-2025   16:15:00
End date and time of board meeting 29-May-2025   17:15:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? No
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? No
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
(III) Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2025-02-18
Indicate Company website link for updated RPT policy of the Company visamanglobalsales.com
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
The Company has not defaulted on loans.


Financial Results — Other than Bank

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Oct-2024 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Revenue From Operations
Revenue from operations 1282768000 2656326000
Other income 341000 10856000
Total Income 1283109000 2667182000
2 Expenses
(a) Cost of materials consumed 1245831000 2449235000
(b) Purchases of stock-in-trade 0 0
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -14173000 108424000
(d) Employee benefit expense 9691000 20165000
(e) Finance costs 29332000 52261000
(f) Depreciation and amortisation expense 2516000 4755000
(g) Other Expenses
1 Other Exp. 3245000 7497000
Total other expenses 3245000 7497000
Total expenses 1276442000 2642337000
3 Profit before exceptional and extraordinary items and tax 6667000 24845000
4 Exceptional items 0 0
5 Profit before extraordinary items and tax 6667000 24845000
6 Extraordinary items 0 0
7 Profit before tax 6667000 24845000
8 Tax Expense
Current tax 1254000 6287000
Deferred tax -2863000 -2863000
Total tax expenses -1609000 3424000
9 Net Profit Loss for the period from continuing operations 8276000 21421000
10 Profit (loss) from discontinuing operations before tax 0 0
11 Tax expense of discontinuing operations 0 0
12 Net profit (loss) from discontinuing operation after tax 0 0
13 Profit (loss) for period before minority interest 8276000 21421000
14 Share of profit (loss) of associates
15 Profit (loss) of minority interest
16 Net profit (Loss) for the period 8276000 21421000
17 Details of equity share capital
Paid-up equity share capital 138120000 138120000
Face value of equity share capital 10 10
18 Reserves excluding revaluation reserve 143660000
19 Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.64 1.66
Diluted earnings (loss) per share from continuing and discontinued operations 0.64 1.66
20 Debt equity ratio 0.0 0.0
21 Debt service coverage ratio 0.0 0.0
22 Interest service coverage ratio 0.0 0.0
23 Disclosure of notes on financial results Textual Information(1)


Text Block

Textual Information(1) As per the Outcome of Board Meeting published on the exchange


Remarks

20 Debt equity ratio
21 Debt service coverage ratio
22 Interest service coverage ratio


Cash flow statement — indirect

A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
1 Statement of cash flows
Cash flows from used in operating activities
Profit before extraordinary items and tax 24845000
2 Adjustments for reconcile profit (loss)
Adjustments to profit (loss)
Adjustments for finance costs 52261000
Adjustments for depreciation and amortisation expense 4755000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for unrealised foreign exchange losses gains 0
Adjustments for dividend income 0
Adjustments for share-based payments 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 2651000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments to profit (loss) 59667000
3 Adjustments for working capital
Adjustments for decrease (increase) in inventories 108424000
Adjustments for decrease (increase) in trade receivables -120360000
Adjustments for decrease (increase) in other current assets 26927000
Adjustments for increase (decrease) in trade payables 3451000
Adjustments for increase (decrease) in other current liabilities 79421000
Adjustments for provisions -24048000
Total adjustments for working capital 73815000
Total adjustments for reconcile profit (loss) 133482000
Net cash flows from (used in) operations 158327000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 5046000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities before extraordinary items 153281000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) operating activities 153281000
4 Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property plant and equipment 0
Purchase of property plant and equipment 71925000
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 0
Income taxes paid (refund) 0
Other inflows (outflows) of cash -1485000
Proceeds from government grants 0
Net cash flows from (used in) investing activities before extraordinary items -73410000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) investing activities -73410000
Cash flows from used in financing activities
Proceeds from issuing shares 145886000
Proceeds from issuing other equity instruments 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 0
Repayments of borrowings 78722000
Dividends paid 0
Interest paid 52261000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities before extraordinary items 14903000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) financing activities 14903000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 94774000
6 Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 94774000
Cash and cash equivalents cash flow statement at beginning of period 33208000
Cash and cash equivalents cash flow statement at end of period 127982000


Statement of Asset and Liabilities

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Equity and liabilities
1 Shareholders' funds
Share capital 138120000
Reserves and surplus 143660000
Money received against share warrants 0
Total shareholders' funds 281780000
2 Share application money pending allotment 0
3 Deferred government grants 0
4 Minority interest
5 Non-current liabilities
Long-term borrowings 14728000
Deferred tax liabilities (net) 0
Foreign currency monetary item translation difference liability account 0
Other long-term liabilities 0
Long-term provisions 0
Total non-current liabilities 14728000
6 Current liabilities
Short-term borrowings 634743000
Trade Payables
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 45505000
Total Trade payable 45505000
Other current liabilities 7881000
Short-term provisions 9683000
Total current liabilities 697812000
Total equity and liabilities 994320000
Assets
1 Non-current assets
i Property, Plant and Equipment and Intangible assets
Property, Plant and Equipment 15625000
Producing properties 0
Intangible assets 829000
Preproducing properties 0
Property, Plant and Equipment capital work-in-progress 66868000
Intangible assets under development or work-in-progress 0
Total Property, Plant and Equipment and Intangible assets 83322000
ii Non-current investments 0
v Deferred tax assets (net) 3963000
vi Foreign currency monetary item translation difference asset account 0
vii Long-term loans and advances 0
viii Other non-current assets 2118000
Total non-current assets 89403000
Current assets
Current investments 0
Inventories 211852000
Trade receivables 415516000
Cash and cash equivalents 127982000
Bank balance other than cash and cash equivalents 0
Short-term loans and advances 140922000
Other current assets 8645000
Total current assets 904917000
Total assets 994320000
Disclosure of notes on assets and liabilities


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Oct-2024 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets
Net Segment Asset
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities
Net Segment Liabilities
Disclosure of notes on segments




Details of Impact of Audit Qualification

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 D. K. Kalyani and Associates Yes 31-Aug-2027


Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Mode of Fund Raising Public Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 27-Jun-2024
Amount Raised 160476000
Report filed for Quarter ended 31-Mar-2025
Monitoring Agency Not Applicable
Monitoring Agency Name, if applicable
Is there a Deviation / Variation in use of funds raised Yes
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders Yes
If Yes, Date of shareholder Approval 21-Dec-2024
Explanation for the Deviation / Variation As per the explanation provided during the variation of objects of IPO proceeds was undertaken.
Comments of the Audit Committee after review The Audit Committee has reviewed the deviation utilized amount and unutilized amount in the object and considered the same as proper.
Comments of the auditors, if any The manner of the utilization of funds including funds utilized for purposes other than those stated in the offer document.
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Capital expenditure requirements of our Company towards setting up of a manufacturing facility at Rajkot Gujarat India As stated aforesaid there is change in premises for setting up of Manufacturing facility and no change in allocated amount for this object. 72189000 72189000 58497000 72189000 The Unutilized amount shall be utilized for the same purpose as mentioned after deviation.
2 Working Capital Requirements Not Applicable 70000000 0 70000000 0
3 General Corporate Purposes Not Applicable 2202000 0 2202000 0
4 Issue Related Expense Not Applicable 16085000 0 16085000 0


Signatory Details

Name of signatory MITULKUMAR SURESHCHANDRA VASA
Designation of person Managing Director
Place RAJKOT
Date 29-May-2025


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity /subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
Total value of transaction during the reporting period